RhumbLine Advisers’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-69,929
| Closed | -$2.05M | – | 2877 |
|
|
2017
Q3 | $2.05M | Buy |
69,929
+1,830
| +3% | +$51.3K | ﹤0.01% | 1609 |
|
|
2017
Q2 | $1.79M | Sell |
68,099
-2,985
| -4% | -$73.4K | ﹤0.01% | 1654 |
|
|
2017
Q1 | $1.66M | Buy |
71,084
+16,784
| +31% | +$414K | ﹤0.01% | 1658 |
|
|
2016
Q4 | $1.37M | Sell |
54,300
-3,496
| -6% | -$88.3K | ﹤0.01% | 1664 |
|
|
2016
Q3 | $1.62M | Buy |
57,796
+5,622
| +11% | +$144K | ﹤0.01% | 1549 |
|
|
2016
Q2 | $1.29M | Sell |
52,174
-6,756
| -11% | -$168K | ﹤0.01% | 1632 |
|
|
2016
Q1 | $1.3M | Buy |
58,930
+4,285
| +8% | +$114K | ﹤0.01% | 1642 |
|
|
2015
Q4 | $1.91M | Buy |
54,645
+1,990
| +4% | +$62.3K | 0.01% | 1383 |
|
|
2015
Q3 | $1.5M | Buy |
52,655
+2,228
| +4% | +$74.9K | 0.01% | 1522 |
|
|
2015
Q2 | $1.68M | Sell |
50,427
-885
| -2% | -$27.2K | 0.01% | 1528 |
|
|
2015
Q1 | $1.45M | Buy |
51,312
+290
| +0.6% | +$7.21K | ﹤0.01% | 1627 |
|
|
2014
Q4 | $1.06M | Buy |
51,022
+1,900
| +4% | +$45.1K | ﹤0.01% | 1771 |
|
|
2014
Q3 | $1.2M | Sell |
49,122
-130
| -0.3% | -$3.45K | ﹤0.01% | 1642 |
|
|
2014
Q2 | $1.41M | Sell |
49,252
-622
| -1% | -$17.3K | ﹤0.01% | 1606 |
|
|
2014
Q1 | $1.4M | Sell |
49,874
-1,291
| -3% | -$31.7K | ﹤0.01% | 1584 |
|
|
2013
Q4 | $1.1M | Sell |
51,165
-3,000
| -6% | -$54.5K | ﹤0.01% | 1750 |
|
|
2013
Q3 | $719K | Sell |
54,165
-434
| -0.8% | -$5.85K | ﹤0.01% | 1982 |
|
|
2013
Q2 | $757K | Buy |
+54,599
| New | +$774K | ﹤0.01% | 1948 |
|
RhumbLine Advisers's PMC Position: Q4 2017 in Review
RhumbLine Advisers sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 69,929 shares — an estimated $2.05M sold.
RhumbLine Advisers first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $2.05M in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- RhumbLine Advisers reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- RhumbLine Advisers sold 69,929 PharMerica Corporation shares in Q4 2017, an estimated $2.05M.
- RhumbLine Advisers first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- RhumbLine Advisers's PharMerica Corporation position peaked at $2.05M in Q3 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.